Medical errors in hospitalized pediatric trauma patients with chronic health conditions

Xiaotong Liu1, Han Yin1, Junxin Shi2

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; The Ohio State University, Columbus, OH, USA.

SAGE Open Medicine
|January 16, 2016
PubMed

Insights

Pediatric trauma patients with chronic conditions have a higher rate of medical errors. This highlights the need for targeted interventions to improve patient safety in this vulnerable group.

Area of Science:

  • Pediatric Trauma Care
  • Patient Safety
  • Medical Error Analysis

Background:

  • Pediatric trauma patients with chronic conditions represent a complex and vulnerable population.
  • Understanding medical error rates in this group is crucial for improving care.
  • Existing research has not fully elucidated the specific risks associated with chronic conditions in pediatric trauma.

Purpose of the Study:

  • To compare the incidence of medical errors in pediatric trauma patients with and without chronic conditions.
  • To identify factors associated with increased medical error risk in this population.

Main Methods:

  • Analysis of the 2009 Kids' Inpatient Database, including 123,303 trauma discharges.
  • Identification of medical errors using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes.
  • Calculation and comparison of medical error rates (per 100 discharges and 1000 hospital days) between groups.

Main Results:

  • Pediatric trauma patients with chronic conditions had a significantly higher medical error rate (4.04 per 100 discharges) compared to those without (1.07 per 100 discharges).
  • The presence of one chronic condition increased the adjusted odds of medical error by 37%, and multiple conditions by 69%.
  • Medical complexity, indicated by chronic conditions, remained a significant predictor of medical error even after accounting for length of stay.

Conclusions:

  • Chronic conditions are independently associated with a substantially higher risk of medical errors in pediatric trauma patients.
  • Further research is warranted to develop and evaluate interventions aimed at reducing medical errors in this high-risk group.
  • Implementing specific guidelines for managing pediatric trauma patients with comorbidities is essential for enhancing patient safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
697
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
864